PTSD rewires the brain at multiple levels, from the overactivation of threat-detection regions to lasting chemical shifts in stress hormones and even changes in how genes are read. Neuroimaging, hormone assays, and molecular studies over the past three decades have converged on a picture in which the disorder is not simply “being stressed” but reflects measurable disruptions in brain circuitry, hormonal signaling, and the epigenetic machinery that controls gene expression. Understanding these layers helps explain why PTSD symptoms persist long after the traumatic event is over, and why the condition responds to some treatments and not others.
The Fear Circuit Gone Haywire
Three brain structures sit at the core of PTSD neurobiology: the amygdala, the prefrontal cortex, and the hippocampus. In a healthy brain, these regions work as a team. The amygdala flags potential threats, the prefrontal cortex evaluates whether those threats are real and dials the alarm up or down, and the hippocampus provides context so the brain can distinguish a car backfiring from a gunshot. In PTSD, this coordination breaks down.
The amygdala becomes hyperactive, firing threat signals at stimuli that would not normally register as dangerous. At the same time, portions of the prefrontal cortex that should be suppressing those false alarms go quiet. Neuroimaging studies consistently show heightened activity in the amygdala and the dorsal anterior cingulate cortex alongside reduced activity in the ventromedial prefrontal cortex, with weakened connections between the prefrontal cortex, hippocampus, and amygdala.1PubMed. Intranasal oxytocin as strategy for medication-enhanced psychotherapy of PTSD: salience processing and fear inhibition processes The practical result is a brain stuck in alarm mode, reacting to reminders of the trauma as though the danger were happening right now.
The hippocampus, meanwhile, shows both structural and functional problems. A large multi-site analysis comparing people with current PTSD to trauma-exposed individuals without the disorder found that hippocampal volume was significantly smaller in the PTSD group.2Biological Psychiatry. Smaller Hippocampal Volume in Posttraumatic Stress Disorder: A Multisite ENIGMA-PGC Study This matters because the hippocampus is responsible for tagging memories with context: where you were, when it happened, how it ended. When hippocampal function is impaired, traumatic memories lose their contextual anchoring and intrude into safe situations as though they are still unfolding.3PubMed Central. Hippocampal dysfunction effects on context memory: possible etiology for posttraumatic stress disorder There is an ongoing debate about whether smaller hippocampal volume is a consequence of trauma exposure or a pre-existing vulnerability factor. Twin studies suggest it may be some of both.
Disrupted Brain Networks
Beyond individual structures, PTSD alters the way large-scale brain networks communicate. Three networks have received the most attention: the default mode network, which handles self-reflection and mind-wandering; the central executive network, which manages working memory and goal-directed thinking; and the salience network, which decides what deserves attention right now.
In PTSD, the salience network appears to be overactive and overly connected, essentially flooding the system with signals that everything is urgent. The default mode network and central executive network, by contrast, tend to be weaker and less well connected, making it harder for the person to stay anchored in the present or think flexibly.4PubMed Central. A Network-Based Neurobiological Model of PTSD: Evidence From Structural and Functional Neuroimaging Studies Researchers have linked each network to specific clusters of symptoms: cognitive difficulties with the central executive network, altered sense of self with the default mode network, and hyperarousal with the salience network.5PubMed Central. Restoring large-scale brain networks in PTSD and related disorders: a proposal for neuroscientifically-informed treatment interventions
This network-level view also helps explain the dissociative subtype of PTSD, where people feel detached from their own body or surroundings. Studies using machine learning to classify PTSD subtypes found distinct patterns of network connectivity between people with classic PTSD and those with the dissociative subtype, particularly in regions involved in emotion regulation and bodily self-awareness.6PubMed Central. Classifying heterogeneous presentations of PTSD via the default mode, central executive, and salience networks with machine learning
The Cortisol Paradox
Most people assume that a stress disorder means too much of the stress hormone cortisol. PTSD turns that assumption sideways. While acute stress does spike cortisol, people with established PTSD often show lower-than-expected cortisol levels throughout the day, including a blunted cortisol response in the morning when levels normally peak. A study of Bosnian war refugees with PTSD found that patients had significantly lower daytime cortisol and essentially no cortisol rise after waking.7PubMed. Hypocortisolism and increased glucocorticoid sensitivity of pro-Inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder
Low cortisol does not mean the stress system is calm. What appears to happen is that the body’s cortisol receptors become hypersensitive, so less cortisol produces a bigger effect at the cellular level. In the same study, immune cells from the PTSD patients required far less of a synthetic steroid to suppress inflammatory signaling, indicating that their tissues had cranked up cortisol sensitivity to compensate for the low circulating levels.7PubMed. Hypocortisolism and increased glucocorticoid sensitivity of pro-Inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder This combination of low cortisol with high sensitivity creates a system that is perpetually on edge: poised to overreact to minor provocations while failing to mount a normal, graded stress response.
Corticotropin-Releasing Hormone Stays Elevated
Upstream of cortisol sits corticotropin-releasing hormone, or CRH, a signaling molecule that tells the pituitary gland to initiate the stress cascade. In PTSD, CRH levels in cerebrospinal fluid are consistently elevated. One study of combat veterans measured CRH at roughly 55 pg/mL in the PTSD group compared with about 42 pg/mL in healthy controls.8PubMed. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder An earlier study in a mixed PTSD sample found a similar pattern, with CRH concentrations averaging around 29 pg/mL versus about 22 pg/mL in comparison subjects.9PubMed Central. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder The differences in absolute numbers between the two studies reflect different assay methods and patient populations, but the direction is the same: CRH is chronically elevated.
Persistently high CRH drives arousal, sleep disruption, and exaggerated startle responses. It also feeds forward into the cortisol system in a way that, over time, may contribute to the paradoxical low-cortisol, high-sensitivity state described above. CRH does not just act through the pituitary; it also influences the amygdala and locus coeruleus directly, amplifying the brain’s threat-detection circuitry from the hormonal side.
Norepinephrine and the Body on Alert
If CRH is the brain’s chemical alarm signal, norepinephrine is the body’s execution arm. The sympathetic nervous system floods the body with norepinephrine during a threat, raising heart rate, sharpening focus, and priming muscles for action. In PTSD, this system does not properly stand down. Adrenergic hyperactivity is a consistent finding and helps explain the hyperarousal symptoms that dominate many patients’ experience: insomnia, irritability, an inability to relax, and heart-pounding reactions to sudden noises.10PubMed Central. Hyperarousal, Dissociation, Emotion Dysregulation and Re-Experiencing-Towards Understanding Molecular Aspects of PTSD Symptoms
This is the pharmacological rationale behind prazosin, an older blood-pressure drug that blocks a type of norepinephrine receptor in the brain. Prazosin has been used off-label for PTSD nightmares specifically because it dampens noradrenergic signaling during sleep. It does not fix the underlying circuit problems, but it can take the edge off the body’s nightly alarm drills enough to improve sleep quality.
GABA, Glutamate, and the Brain’s Braking System
The brain regulates its own excitability through a balance between excitatory signals (primarily glutamate) and inhibitory signals (primarily GABA). PTSD disrupts both sides. GABA function appears to be reduced, weakening the brain’s ability to put the brakes on fear responses. This is especially relevant in the amygdala, where GABA-releasing neurons normally help control fear conditioning and allow learned fear to fade over time.11PubMed Central. Involvement of the GABAergic system in PTSD and its therapeutic significance
On the other side of the equation, stress drives up glutamate levels in the hippocampus, contributing to a shift in the excitatory-inhibitory balance that can damage neurons over time.12PubMed Central. Glutamate and GABA imbalance promotes neuronal apoptosis in hippocampus after stress The end result is a brain that has trouble both generating calm and extinguishing old fear memories, a double hit that may help explain why trauma memories in PTSD are so sticky and resistant to natural fading.
The Endocannabinoid Deficit
Your body makes its own cannabis-like molecules, the endocannabinoids, which play a quieting role in the stress response. They help dampen amygdala activity and promote the extinction of fear memories. In PTSD, levels of anandamide, a key endocannabinoid, are reduced, and the CB1 receptors that respond to endocannabinoids appear to be upregulated, likely as the brain’s attempt to compensate for the shortfall. Higher CB1 receptor availability in the amygdala has been tied to abnormal threat processing and more severe hyperarousal symptoms in trauma survivors.13PubMed Central. Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder
This finding has fueled interest in whether cannabinoid-based therapies might help restore the deficit, though research remains early and the therapeutic window between helpful and harmful is unclear. It also underscores a broader theme: PTSD is not just about systems being overactive. Several of the body’s built-in calming systems are simultaneously weakened.
Neuropeptide Y and Built-In Resilience
Not everyone who experiences severe trauma develops PTSD. One biological factor that appears to protect against the disorder is neuropeptide Y, a small signaling molecule abundant in brain regions involved in emotion and stress. Animal studies consistently show that NPY promotes coping with stress, and human data suggest that higher NPY levels may act as a resilience factor against PTSD.14PubMed Central. Neuropeptide Y and posttraumatic stress disorder Conversely, reduced NPY in the central nervous system has been associated with the disorder. Translational research is exploring whether boosting NPY signaling could serve as a therapeutic strategy, though clinical applications have not yet materialized.15PubMed. Neuropeptide Y, resilience, and PTSD therapeutics
Neuroinflammation and Microglia
The brain has its own immune cells, called microglia, that act as first responders to injury and infection. In PTSD, these cells appear to be chronically activated. A mouse model of PTSD found that microglia were the dominant immune cell type responding to trauma-like stress, with their numbers increasing significantly after exposure. When researchers either deleted or inhibited microglia in these mice, PTSD-like behaviors improved.16PubMed Central. Microglial deletion and inhibition alleviate behavior of post-traumatic stress disorder in mice While mouse models do not translate directly to humans, the finding aligns with growing evidence that chronic low-grade inflammation in the brain contributes to PTSD symptom maintenance. It also connects back to the cortisol paradox: the heightened immune sensitivity seen in PTSD patients may reflect, in part, insufficient cortisol-mediated suppression of neuroinflammatory processes.
FKBP5 and the Epigenetics of Stress
Epigenetics refers to changes in how genes are activated or silenced without altering the underlying DNA sequence. One of the most studied epigenetic players in PTSD is the FKBP5 gene, which regulates how well cortisol receptors function. Certain genetic variants of FKBP5 interact with environmental stressors and epigenetic modifications to produce a state in which the gene becomes disinhibited, meaning it runs without its normal brakes. This disinhibition has been linked to abnormal stress responses in both animals and humans.17PubMed Central. Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational Implications
The interaction between genetics and epigenetics at FKBP5 is unusually specific. A study of combat veterans found that methylation levels of the FKBP5 gene differed between those with and without PTSD, but only among veterans carrying a particular risk variant of the gene (the T allele of rs1360780). Veterans with that variant and PTSD showed higher methylation, and methylation levels correlated with symptom severity. Veterans without the risk variant showed no such difference.18PubMed. Allele-specific DNA methylation level of FKBP5 is associated with post-traumatic stress disorder This gene-by-environment-by-epigenetic interaction is a vivid example of why PTSD cannot be reduced to either “it’s genetic” or “it’s caused by trauma.” Both matter, and they influence each other at the molecular level.
Genome-Wide Epigenetic Changes
The epigenetic story goes well beyond a single gene. Studies examining the entire genome have found hundreds of sites where DNA methylation differs in people with trauma histories. An analysis of brain tissue from individuals who had experienced childhood abuse and died by suicide identified over 360 gene promoters with altered methylation compared to controls. The majority of these changes occurred in neurons rather than other cell types, and many of the affected genes were involved in cellular and neuronal flexibility.19JAMA Psychiatry. Genome-wide Epigenetic Regulation by Early-Life Trauma
Childhood trauma also appears to leave a distinct epigenetic signature compared with trauma experienced later in life. A study comparing PTSD patients with and without histories of childhood abuse found that a far larger proportion of gene-expression changes were accompanied by DNA methylation changes in the childhood-abuse group (roughly 69%) compared with those who experienced trauma only in adulthood (about 34%).20PubMed Central. Childhood maltreatment is associated with distinct genomic and epigenetic profiles in posttraumatic stress disorder This is consistent with the broader developmental neuroscience view that the brain is especially sensitive to epigenetic reprogramming during early life, and it may partially explain why childhood trauma carries a higher risk for PTSD than equivalent adult trauma.
One particularly interesting epigenetic target is the KITLG gene (Kit ligand), which showed the strongest association with altered cortisol stress reactivity in people who had experienced childhood trauma.21Nature Communications. Genome-wide DNA methylation levels and altered cortisol stress reactivity following childhood trauma in humans KITLG is involved in cell growth and survival in various tissues, and its connection to the cortisol system is still being mapped. But the finding illustrates a key point: trauma does not just change the brain through circuit-level wear and tear. It reaches down into the molecular machinery that controls which genes are active and which are silenced.
Fear Extinction, BDNF, and Why Trauma Memories Persist
One of the defining features of PTSD is the failure of fear extinction, the process by which the brain learns that a formerly dangerous cue is now safe. In healthy fear extinction, repeated safe exposure to a trauma reminder gradually weakens the fear response. In PTSD, this process stalls. The neurotrophin BDNF (brain-derived neurotrophic factor) plays a central role in the synaptic plasticity that extinction requires. People and animals with certain BDNF gene variants (the Met allele) show impaired extinction learning after fear conditioning, along with impaired plasticity in the hippocampus.22PubMed Central. Fear Conditioning, Synaptic Plasticity, and the Amygdala: Implications for Posttraumatic Stress Disorder Because BDNF appears to enhance fear extinction, researchers have proposed that targeting BDNF signaling could improve treatment outcomes in PTSD.23PubMed Central. Fear extinction and BDNF: translating animal models of PTSD to the clinic
This is where the emerging interest in psychedelics connects to PTSD neurobiology. Both serotonergic psychedelics and ketamine stimulate BDNF signaling through glutamatergic neurons, promoting the formation of new synapses. These neuroplastic changes may explain their early promise in conditions including PTSD. MDMA, which has advanced furthest in clinical trials for PTSD specifically, presents a more complicated picture: it boosts BDNF through serotonin-dependent pathways but may also have negative effects on neurotrophin signaling in the hippocampus.24PubMed. Changing your mind: neuroplastic mechanisms underlying the therapeutic effect of psychedelics in depression, PTSD, and addiction Understanding these mechanisms at the molecular level is increasingly seen as essential for knowing which patients might benefit and what the long-term trade-offs look like.
Sex Differences in PTSD Neurobiology
Women develop PTSD at roughly twice the rate of men, even when controlling for trauma type. The neurobiological explanation is not settled, but one compelling line of research points to estrogen. Estrogen influences the same prefrontal-amygdala circuitry that goes awry in PTSD, and fluctuations in estrogen levels across the menstrual cycle appear to affect fear extinction. The hypothesis is that low-estrogen phases of the cycle make extinction learning harder, potentially widening the window of vulnerability to developing PTSD after trauma.25PubMed Central. Estrogen and extinction of fear memories: implications for posttraumatic stress disorder treatment
Supporting this, a study of women with PTSD found that low estrogen levels were associated with extinction deficits, suggesting that estrogen status at the time of trauma or early afterward could be a vulnerability factor.26PubMed Central. Estrogen levels are associated with extinction deficits in women with posttraumatic stress disorder If this holds up, it could eventually inform the timing of exposure-based therapies or lead to hormone-augmented treatment strategies. It also highlights a broader blind spot: most early PTSD neurobiology research was conducted in male combat veterans, and the field is still catching up on how these mechanisms differ by sex.
The Gut-Brain Axis After Trauma
One of the more surprising directions in PTSD research involves the gut. The community of microorganisms in the gastrointestinal tract communicates with the brain through several channels, including immune signaling, microbial metabolites, and the vagus nerve. Evidence is building that the gut microbiome influences inflammation, stress hormone regulation, and even neurotransmitter availability in ways that may contribute to PTSD vulnerability and maintenance. The communication runs both ways: stress and trauma alter the gut environment, and changes in gut microbes can, in turn, influence brain function and behavior. While this line of research is younger than the circuit and hormone work, it is expanding the boundaries of what counts as PTSD neurobiology beyond the skull itself.
Genetic Architecture and Shared Risk
PTSD runs in families, but separating genetic predisposition from shared environment has been difficult. Recent large-scale genetic analyses estimate that common genetic variants account for roughly 5 to 7 percent of the variation in PTSD risk, a modest number that reflects the outsized role of the traumatic event itself.27ScienceDirect. M35. GENETIC ARCHITECTURE AND PLEIOTROPY: CONNECTING MAJOR DEPRESSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, AND AMYGDALA VOLUME Intriguingly, PTSD shares a high degree of genetic overlap with major depression, with Bayesian modeling estimating a 92% global genetic correlation between the two disorders and roughly 11,000 shared genetic variants.27ScienceDirect. M35. GENETIC ARCHITECTURE AND PLEIOTROPY: CONNECTING MAJOR DEPRESSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, AND AMYGDALA VOLUME Yet the overlap is not total: about 700 depression-associated variants had no detectable effect on PTSD, pointing to partial genetic specificity between the two conditions. This genetic architecture reinforces the clinical reality that PTSD and depression often co-occur, frequently look similar on brain scans, and yet respond differently to certain treatments. They share most of the biological ground floor but have distinct upper stories.